Based on our research, Dr Bijan Feriduni is widely viewed as a high‑end European surgeon with a strong focus on complex and repair work, often grouped with Hattingen, Bisanga, and Fuegenix. 12 We have seen patients choose him over other respected European names due to consistent outcomes in difficult cases and his standing as a leading repair surgeon. 1 He is also described as a plan‑ahead doctor who targets sufficient rather than extreme density. 3 At the same time, some shortlists include him with little technical detail, which suggests his reputation leans more on broad community regard and selected case results than deep, widely shared breakdowns of technique. 4

Our read is that Dr Feriduni is a technically respected, repair‑capable surgeon whose main trade‑offs are cost and questions about how some repair work is structured and billed. 15 We have read a meaningful amount of positive feedback, including a patient with extensive loss who reports being extremely happy after two surgeries and has recommended him to friends. 6 Pricing is consistently flagged as very high, especially for graft punch‑out in repairs, which a seasoned commenter characterizes as exploitative at 10 €/graft. 15 We have also come across criticism of a challenging repair where the patient allegedly needed more surgeries than initially indicated to remove mis‑angled grafts, raising concerns about expectation‑setting in complex cases. 5 Overall, high skill at a premium price, with strong subjective outcomes in several accounts, but enough concern around pricing structure and at least one difficult repair plan that we would stay somewhat cautious. 1562

From what we have seen, technicians handle extractions while Dr Feriduni performs all incisions and a substantial share of placement, pointing to a doctor‑led but team‑executed workflow. The same patient noted more grafts were taken than planned and that the clinic discounted the overage, suggesting some flexibility once donor yield is known. 7 A density comparison places him around 50 grafts/cm² for planning rather than ultra‑dense packing, which fits a resource‑preserving approach. 3 In repairs, he performs graft punch‑out with re‑use of those grafts, distinct from destructive methods like electrolysis. 5 Logistics appear organized: the clinic is in Hasselt, with a hotel partnership and driver service noted by a patient. 6 Initial consults can start by phone and move to email photos, indicating a standard remote triage before in‑person surgery. 1

We have reviewed a case of extensive loss treated in two stages where the patient reports being extremely happy with coverage and aesthetics. 6 Another report highlights natural, age‑appropriate hairlines and an artistic approach to design. 1 That same poster recommended him to friends and described similarly positive impressions in a close contact, although detailed graft counts and density metrics were not provided. 6 He is also described among surgeons who plan at roughly 50 grafts/cm² to simulate fullness without maximal dense packing. 3 At the same time, a critical repair account describes a patient told two surgeries would fix a mis‑angled, multi‑hair hairline who is now reportedly on a fourth procedure with some multis remaining. 5 We do not see quantitative growth data here, so while some results look very good visually, complex repairs can stretch over multiple stages and may not fully erase prior issues. 156

One detailed account describes the clinic experience as very positive: staff were described as wonderful, the patient felt fully comfortable, and long‑tenured technicians worked smoothly together. 6 The doctor was characterized as down‑to‑earth and compassionate, with clear pride in collaborating on outcomes, and a best friend reportedly had the same impression. 6 Communication often proceeds by email after an initial phone contact, which feels structured but not overly hand‑holding. 16 Hasselt is described as a comfortable small town, with an associated hotel that offers a discount and organized driver service for patients. 6 We have also seen a separate criticism around a repair plan that required more surgeries than initially suggested, which suggests some patients may feel planning or expectation management for complex cases could be tighter. 5

Based on our research, Dr Feriduni operates at the premium end of the market. Reports cite typical FUE rates of about 4–5 €/graft with large‑session totals in the high five figures, and several users note this is beyond many budgets. 1 We have also seen a 6 €/graft figure referenced. 8 One thread claims a 35,000 € per day minimum, which led a would‑be patient to cancel. 9 For repair punch‑outs, 10 €/graft has been reported and criticized as overpriced. 5 There is at least one case where additional grafts beyond plan were discounted, bringing the effective rate down to roughly $3–3.5 per graft. 7 In short, very high base rates, possible daily minimums, and costly punch‑outs, with occasional overage discounts depending on the case. 15897

The clearest risk is financial. Pricing is high, and the reported 10 €/graft punch‑out fee in repairs can make multi‑stage corrections extremely costly. 1589 We also note risk around planning and expectation‑setting for repairs: in one account, a patient told two surgeries would suffice is now reportedly on a fourth and still has some multis. 5 That same feedback argues biology makes a single punch‑out session unlikely to remove all offending grafts, which can catch patients off guard. 5 We have not seen reports here of catastrophic growth failure or donor overharvesting attributed directly to this clinic, but repeated procedures do carry cumulative burden. 5 Much of the praise is visual and subjective rather than data‑rich, so results may vary by case, especially in advanced or repair scenarios. Conservative expectations are sensible. 1563

From what we have seen, this is a credible option for patients who prioritize surgeon reputation and bespoke planning, especially for complex or repair work, and who can tolerate premium pricing. 1562 For difficult repairs, some patients explicitly shortlist him alongside Hattingen, Bisanga, and Fuegenix. 2 High‑Norwood patients can also do well, as shown by a two‑stage case with a very satisfied outcome. 6 Cost is a real barrier: several users view the fees as out of reach, and at least one patient canceled after learning about a reported daily minimum. 1589 We have also seen a repair case that required more unplanned surgeries, which suggests that highly price‑sensitive or risk‑averse patients might prefer other high‑skill options or mixed strategies that include non‑surgical removal. 5 Bottom line: worth considering for patients who value a high‑reputation, measured‑density approach and can accept the premium and potential for staged repairs; those seeking lower‑cost or single‑stage solutions may find higher‑certainty options elsewhere. 156923